Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery
Recruiting
Observational Study
Scoliosis; Spinal Fusion; Blood Transfusion; Operative Blood Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 17
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Mehdi Trifa · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Spine surgery for scoliosis correction in pediatric patients is a major procedure associated with a high risk of perioperative blood loss. Homologous blood transfusion carries inherent risks, including immunological reactions, infections, and increased healthcare costs. Identifying high-risk patients is crucial to optimize blood conservation strategies. This retrospective study aims to identify pr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient aged under 18 years (\< 18 years old).
* Programmed surgical correction for scoliosis (including idiopathic, neuromuscular, and congenital etiologies).
* Instrumented surgery involving posterior spinal arthrodesis.
Exclusion Criteria:
* Revision spine surgeries.
* Kn…
Contacts